India As A Key Player In The Progress Of The Homoeopathy Drug Industry

MoU signed between Homoeopathic Pharmacopoeia Convention of the United States and CCRH for cooperation in the field of Homoeopathic Medicine 

Minister of State (Independent Charge) for AYUSH Shripad Yesso Naik inaugurated the World Integrated Medicine Forum on Regulation of Homeopathic Medicinal Products: National and Global strategies in New Delhi. Speaking on the occasion, the AYUSH Minister said that in India, Homoeopathy has been well institutionalized and we have 235 homoeopathic hospitals and more than 8000 clinics in public sector. He said that most of production plants in India are GMP-compliant and adhere to policies related to quality, packaging and distribution. He further said that all these manufacturing units are bound by Drugs & Cosmetics Law and their renewal of license depends on regular quality check and thorough inspections.
In his inaugural address Shri Shripad Naik remarked that there is clearly a need for a high-level strategic exchange platform, where stakeholders can meet outside their immediate work related context and this forum could address that need. In the other countries Homoeopathy remains largely under-utilized due to lack of availability of homoeopathic medicines or stringent or non-existent regulatory provisions for these medicines, the Minister added.
On this occasion an MoU was also signed between Homoeopathic Pharmacopoeia Convention of the United States (HPCUS) and Indian bodies – Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) and Central Council for Research in Homoeopathy (CCRH) on cooperation in the field of Homoeopathic Medicine.  It is hoped that this agreement will be a benchmark for many more agreements to follow with the aim to develop and harmonise homoeopathic pharmacopoeias and to strengthen regulatory provisions for homoeopathy in the whole world.  The two day event is organised by Ministry of AYUSH and  Central Council for Research in Homeopathy (CCRH) and supported by Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIMH) & Central Drugs Standard Control Organization (CDSCO). This is the first-of-its-kind forum considering the increased perception of the international world towards India as a key player in the progress of the homoeopathy drug industry. Drug lawmakers, regulators, manufacturers and pharmacopeial experts from various regulatory authorities, eminent scientific organisations and pharmaceutical industries  from 25 countries, are participating in the two days forum to strategize the  actionable aspects in the homoeopathic drug industry, which, in turn, will promote global harmonisation in the sector.